relatively similar proportions of physicians who had graduated <11 years, 11 to 20 years, 21 to 30 years, or >30 years before the study period. Table 1. Physician Characteristics The proportion of oncologists who received any payments within the
Search Results
Increasing Financial Payments From Industry to Medical Oncologists in the United States, 2014–2017
Mohammed W. Rahman, Niti U. Trivedi, Peter B. Bach, and Aaron P. Mitchell
Efficacy and Toxicity Analysis of mFOLFIRINOX in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms
Michele Borghesani, Anna Reni, Eleonora Lauricella, Alice Rossi, Viola Moscarda, Elena Trevisani, Irene Torresan, Taymeyah Al-Toubah, Elisabetta Filoni, Claudio Luchini, Riccardo De Robertis, Luca Landoni, Aldo Scarpa, Camillo Porta, Michele Milella, Jonathan Strosberg, Mauro Cives, and Sara Cingarlini
interest. All tests were 2-sided and statistical significance was declared at P <.05. Statistical analysis was performed using MedCalc version 12.7 (MedCalc Software Ltd). Results Patient Characteristics Patient demographics and tumor
Morphologic and Molecular Characteristics of De Novo AML With JAK2 V617F Mutation
Juliana E. Hidalgo-López, Rashmi Kanagal-Shamanna, L. Jeffrey Medeiros, Zeev Estrov, C. Cameron Yin, Srdan Verstovsek, Sergej Konoplev, Jeffrey L. Jorgensen, Mohammad M. Mohammad, Roberto N. Miranda, Chong Zhao, John Lee, Zhuang Zuo, and Carlos E. Bueso-Ramos
myelofibrosis (MF). 3 Bone marrow (BM) specimens from these patients usually show characteristic findings, including atypical megakaryocytic hyperplasia with or without reticulin fibrosis. JAK2 V617F mutation also has been reported in chronic myelomonocytic
Impact of NCI-Mandated Scientific Review on Protocol Development and Content
Ning Ning, Jingsheng Yan, Xian-Jin Xie, and David E. Gerber
following characteristics: year, disease under study, phase and type (interventional/noninterventional), and sponsor type (institutional/industrial). Institutional trials included investigator-initiated trials with a local study chair or a study chair at
A Hospital-Wide Intervention to Improve Compliance With TNM Cancer Staging Documentation
Jason H. Lee, Tariq Mohamed, Celia Ramsey, Jihoon Kim, Shelly Kane, Kathryn A. Gold, Farhoud Faraji, and Joseph A. Califano III
association of patient, provider, and treatment team characteristics, including 1- or 2-month deadline, with the prevalence of and time to staging. Patient characteristics included age, sex, race, and Charlson comorbidity index (CCI) score. Provider
Validation of the PREDICT Prognostication Tool in US Patients With Breast Cancer
Nickolas Stabellini, Lifen Cao, Christopher W. Towe, Megan E. Miller, Artur H. Sousa-Santos, Amanda L. Amin, and Alberto J. Montero
therapies, such as chemotherapy, endocrine therapy, trastuzumab, and bisphosphonates, on OS in patients with breast cancer. 4 , 5 Provided with basic inputs of an individual patient’s clinicopathologic characteristics, PREDICT provides personalized
Role of Locoregional Treatment in Vulvar Cancer With Pelvic Lymph Node Metastases: Time to Reconsider FIGO Staging?
Ashwin Shinde, Richard Li, Arya Amini, Yi-Jen Chen, Mihaela Cristea, Wenge Wang, Mark Wakabyashi, Ernest Han, Catheryn Yashar, Kevin Albuquerque, Sushil Beriwal, and Scott Glaser
backward selection of variables at a significance level of P <.10. An alpha threshold of 0.05 was chosen for statistical significance. Statistical analyses were performed using SPSS Statistics, version 24.0 (IBM Corp). Results Patient Characteristics A
Variation in National Use of Long-Term ADT by Disease Aggressiveness Among Men With Unfavorable-Risk Prostate Cancer
Vinayak Muralidhar, Paul J. Catalano, Gally Reznor, Brandon A. Mahal, Toni K. Choueiri, Christopher J. Sweeney, Neil E. Martin, Clair J. Beard, Yu-Wei Chen, Michelle D. Nezolosky, Karen E. Hoffman, Felix Y. Feng, Quoc-Dien Trinh, and Paul L. Nguyen
, treatment, and survival data in addition to patient-specific demographic characteristics, covering 28% of the US population and 97% of incident cancers. 12 SEER was linked to Medicare administrative data, which contains insurance claims data for patients
Telemedicine Adoption in an NCI-Designated Cancer Center During the COVID-19 Pandemic: A Report on Patient Experience of Care
Krupal B. Patel, Amir Alishahi Tabriz, Kea Turner, Brian D. Gonzalez, Laura B. Oswald, Heather S.L. Jim, Oliver T. Nguyen, Young-Rock Hong, Nasrin Aldawoodi, Biwei Cao, Xuefeng Wang, Dana E. Rollison, Edmondo J. Robinson, Cristina Naso, and Philippe E. Spiess
the study period into the same 4 time intervals. Statistical Analyses Patient characteristics were summarized using descriptive statistics, including median and range for continuous measures and proportions and frequencies for categorical
Representation of Sexual and Gender Minority People in Patient Nondiscrimination Policies of Cancer Centers in the United States
Iman K. Berrahou, Ava Snow, Megan Swanson, and Juno Obedin-Maliver
selected because of their particular relevance to the SGM population with regard to enumeration of protections in nondiscrimination policies across federal and state laws. Analyses were performed to determine whether cancer center characteristics impacted
